What are the Challenges in the Regulatory Approval Process?
The approval process for new cancer treatments is rigorous and can be time-consuming. One challenge is the need for extensive and expensive clinical trials. Regulatory agencies must balance the urgency for new treatments with the necessity for thorough testing. Additionally, there can be differences in regulatory standards between countries, complicating global drug approval.
